A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 43
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : DNP
Long Form : diabetic nephropathy
No. Year Title Co-occurring Abbreviation
2022 Genetic Variants and Their Associations to Type 2 Diabetes Mellitus Complications in the United Arab Emirates. DPN, DR, GWAS, SNPs, T2DM
2021 Clinical Significance of Non-invasive Skin Autofluorescence Measurement in Patients with Diabetes: A Systematic Review and Meta-analysis. AGE, D-MVE, DM, DPN, DR, MEDLINE, SAF
2021 Comparative Evaluation of Orthostatic Hypotension in Patients with Diabetic Nephropathy. BP, NDCKD
2021 Patterns of Toll-Like Receptor Expressions and Inflammatory Cytokine Levels and Their Implications in the Progress of Insulin Resistance and Diabetic Nephropathy in Type 2 Diabetic Patients. CRP, IFN-gamma, IL-6, INS, PB, T2DM, TLR2, TLR4, TLRs, TNF-alpha
2020 Podocyte Integrin-beta 3 and Activated Protein C Coordinately Restrict RhoA Signaling and Ameliorate Diabetic Nephropathy. aPC, PARs
2019 Methods to Detect Endoplasmic Reticulum Stress and Apoptosis in Diabetic Nephropathy. ATF6, ER, PKR, UPR
2017 Choroidal thickness alterations in diabetic nephropathy patients with early or no diabetic retinopathy. CT, EDI-OCT
2017 Clinical variables differentiating diabetic from nondiabetic kidney disease in patients with diabetes: A single-center study. DM, DRP
2017 Farnesoid X Receptor Agonism Protects against Diabetic Tubulopathy: Potential Add-On Therapy for Diabetic Nephropathy. ER, FXR, TUDCA
10  2016 Caspase-1, but Not Caspase-3, Promotes Diabetic Nephropathy. ---
11  2016 Changes in the inflammatory markers with advancing stages of diabetic nephropathy and the role of pentraxin-3. eGFR, hs-CRP, IL, PTX3, TNF
12  2016 Exogenously administered adenosine attenuates renal damage in streptozotocin-induced diabetic rats. BUN, DM, KIM-1, STZ, TNF-alpha
13  2016 Stabilization of endogenous Nrf2 by minocycline protects against Nlrp3-inflammasome induced diabetic nephropathy. ---
14  2016 The correlation of inflammatory markers and plasma vaspin levels in patients with diabetic nephropathy. eGFR, hs-CRP, IL, TNF
15  2014 Glucose specifically regulates TRPC6 expression in the podocyte in an AngII-dependent manner. Ang II
16  2013 Effect of long acting insulin supplementation on diabetic nephropathy in Wistar rats. ---
17  2013 Progression of diabetic nephropathy, risk of end-stage renal disease and mortality in patients with type-1 diabetes. ESRD, T1D
18  2012 Higher mortality of patients on haemodialysis with pancreatic diabetes compared to type 2-diabetes. ESRD, HD, PDM
19  2011 Clinical versus histological diagnosis of diabetic nephropathy--is renal biopsy required in type 2 diabetic patients with renal disease? ESRD, vNP
20  2010 Pharmacokinetic characterization of the novel pulmonary delivery excipient fumaryl diketopiperazine. ADME, CLD
21  2010 Protective effects of irbesartan and alpha lipoic acid in STZ-induced diabetic nephropathy in rats. ALA, Ang, IRB, STZ
22  2009 Evidence of O-linked N-acetylglucosamine in diabetic nephropathy. O-GlcNAc
23  2009 Study of ACEI versus ARB in managing hypertensive overt diabetic nephropathy: long-term analysis. ACEI, ARB
24  2008 Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on streptozotocin-induced diabetic nephropathy. ACE, Ang, i.p, IRB, STZ
25  2008 Urinary matrix metalloproteinase -8, -9, -14 and their regulators (TRY-1, TRY-2, TATI) in patients with diabetic nephropathy. MMP-9, PMN, TATI, TRY
26  2006 Diabetic nephropathy: a frontier for personalized medicine. ---
27  2006 Effect of ACE and AT-2 inhibitors on mortality and progression to microalbuminuria in a nested case-control study of diabetic nephropathy in diabetes mellitus type 2: results from the GENDIAN study. ---
28  2006 Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy. ESRD
29  2006 Increased expression of heparanase in overt diabetic nephropathy. GBM, HPSE, HS, mRNA, STZ
30  2006 Proteinuria in diabetic patients--is it always diabetic nephropathy? DRP, NDKD
31  2006 Rate of decline of GFR and progression of vascular disease in type 2 diabetic patients with diabetic or vascular nephropathy during the last three years before starting dialysis therapy. BP, Cr, GFR, vNP
32  2005 Diabetic nephropathy in children with type 1 diabetes mellitus in Bahrain. HbA1c, T1DM
33  2005 Multiple metabolic hits converge on CD36 as novel mediator of tubular epithelial apoptosis in diabetic nephropathy. PTEC, TED
34  2004 Anti-proteinuric effects of combination therapy with enalapril and losartan in patients with nephropathy due to type 2 diabetes. ATII, MAP
35  2001 Prevalence, course and risk factors of diabetic nephropathy in type-2 diabetes mellitus. MA, MAA, NA, pts, RP, SE, UAE
36  2000 Evaluation of nuclide renal dynamic image in diagnosing diabetic nephropathy. ---
37  1999 Prevalence of "syndrome X" features in parents of type 1 diabetic patients with or without nephropathy. NEFAs, SXS
38  1995 Urinary excretion of protectin (CD59), complement SC5b-9 and cytokines in membranous glomerulonephritis. MAC, MGN, UCr
39  1995 [Nephropathy and microalbuminuria in type II diabetes]. ---
40  1994 Urinary excretion of cytokines and complement SC5b-9 in idiopathic membranous glomerulonephritis. IMGN, sC5b-9
41  1992 Is increased erythrocyte sodium-lithium countertransport a useful marker for diabetic nephropathy? ---
42  1989 Importance of cardiovascular autonomic dysfunction in IDDM subjects with diabetic nephropathy. CAD, IDDM
43  1985 Tubular dysfunctions in the diagnostic differentiation of glomerulonephritis, pyelonephritis, and diabetic nephropathy. GN, PN